Corline Biomedical

About:

Corline Biomedical is a pharmaceutical company based in Sweden.

Top Investors: EASME - EU Executive Agency for SMEs

Description:

Corline Biomedical is a pharmaceutical company based in Sweden. The company develops, manufactures, and markets heparin based solutions to improve kidney transplantation, cell therapies and applications in the evolving field of regenerative medicine. Corline was founded in 1991.

Total Funding Amount:

$2.36M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Uppsala, Uppsala Lan, Sweden

Founded Date:

1991-01-01

Founders:

Henrik Nittmar

Number of Employees:

1-10

Last Funding Date:

2017-03-01

IPO Status:

Private

Industries: